Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Monocyte-derived DCs (moDCs) are the most commonly used DC subtype in cancer vaccines, and the induction of tumor-specific CTLs in vitro by mRNA-transfected moDCs has been reported in several studies [4-10].”
In the citing paper
“Electroporation of DCs with mRNA encoding specific tumor-associated antigens is an effective non-viral method to stimulate T cell responses in vitro and in vivo[4-11].”
In the citing paper
“Recently, it was shown that human DCs could be transfected with RNA and were capable of inducing primary antigen-specific CTLs.9”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green fluorescent protein as a marker for gene expression
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W., & Prasher, D. C. (1994) · Science · doi:10.1126/science.8303295 · Cited by 6,802
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.389 · Cited by 2,500
Proliferating dendritic cell progenitors in human blood.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.83 · Cited by 1,840
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Lin, K. Y., Guarnieri, F., Staveley-O’Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., & Wu, T. ‐. (1996) · PubMed · Cited by 1,003
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.465 · Cited by 915
Self-citationZitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.87 · Cited by 828
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.65 · Cited by 725
Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
Salter, R. D., Howell, D. N., & Cresswell, P. (1985) · Immunogenetics · doi:10.1007/bf00375376 · Cited by 566
Paglia, P., Chiodoni, C., Rodolfo, M., & Colombo, M. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.317 · Cited by 542
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
Keene, J.-A., & Forman, J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.3.768 · Cited by 500
Tsang, K. Y., Zaremba, S., Nieroda, C. A., Zhu, M. Z., Hamilton, J. M., & Schlom, J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.13.982 · Cited by 498
Siliciano, R. F., Lawton, T., Knall, C., Karr, R. W., Berman, P., Gregory, T., & Reinherz, E. L. (1988) · Cell · doi:10.1016/0092-8674(88)90078-5 · Cited by 369
Porgador, A., & Gilboa, E. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.255 · Cited by 362
Self-citationMechanisms of antigen uptake for presentation
Lanzavecchia, A. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80124-5 · Cited by 347
Wu, T. C., Guarnieri, F. G., Staveley-O'Carroll, K. F., Viscidi, R. P., Levitsky, H. I., Hedrick, L., Cho, K. R., August, J. T., & Pardoll, D. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11671 · Cited by 344
Induction of antitumor immunity using bone marrow-generated dendritic cells
Porgador, A., Snyder, D., & Gilboa, E. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.8.2918 · Cited by 314
Self-citationCelis, E., Tsai, V, Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., & Serra, H. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2105 · Cited by 306
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., & Moser, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240317 · Cited by 291
von Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B., & Whitton, J. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1072-1079.1996 · Cited by 279
Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.
Reeves, M. E., Royal, R. E., Lam, J. S., Rosenberg, S. A., & Hwu, P. (1996) · PubMed · Cited by 208
Nair, S., Zhou, F., Reddy, R., Huang, L., & Rouse, B. T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.609 · Cited by 175
Self-citationBakker, A. B. H., Marland, G., de Boer, A. J., Huijbens, R. J. F., Danen, E. H. J., Adema, G. J., & Figdor, C. G. (1995) · PubMed · Cited by 161
Generation of antigen-specific CD8+ CTLs from naive precursors.
Mehta-Damani, A., Markowicz, S., & Engleman, E. G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.3.996 · Cited by 137
Ossevoort, M. A., Feltkamp, M. C. W., van Veen, K. J. H., Melief, C. J. M., & Kast, W. M. (1995) · Journal of Immunotherapy · doi:10.1097/00002371-199508000-00002 · Cited by 133
Morse, M. A., Zhou, L., Tedder, T. F., Lyerly, H. K., & Smith, C. A. (1997) · Annals of Surgery · doi:10.1097/00000658-199707000-00002 · Cited by 112
Self-citationThe Endogenous Pathway of MHC Class II Antigen Presentation
Lechler, R. I., Aichinger, G., & Lightstone, L. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00703.x · Cited by 103
Kern, D. E., Klarnet, J. P., Jensen, M. C., & Greenberg, P. D. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4303 · Cited by 96
Macatonia, S. E., Patterson, S., & Knight, S. C. (1991) · PubMed · Cited by 92
Rock, K. L., & Clark, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3721 · Cited by 91
Nair, S. K., Babu, J. S., Dunham, R. G., Kanda, P., Burke, R. L., & Rouse, B. T. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4062-4069.1993 · Cited by 80
Self-citationRouse, R. J. D., Nair, S. K., Lydy, S. L., Bowen, J. C., & Rouse, B. T. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5685-5689.1994 · Cited by 69
Self-citationA fluorescence-based assay for quantitation of lymphokine-activated killer cell activity
Volgmann, T., Klein-Struckmeier, A., & Mohr, H. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90379-7 · Cited by 62
Immunity to Human Papillomavirus—Associated Cervical Neoplasia
Stern, P. L. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60863-5 · Cited by 44
Cited by
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Dendritic Cells in Cancer Immunotherapy
Fong, L., & Engleman, E. G. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.245 · Cited by 680
The use of dendritic cells in cancer immunotherapy
Schuler, G., Schuler-Thurner, B., & Steinman, R. M. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00015-3 · Cited by 631
Metadata
- Authors
- Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., & Gilboa, E.
- Venue
- Nature Biotechnology
- Published
- 1998-04
- Volume
- 16
- Issue
- 4
- Pages
- 364-369
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2036291495
- Cited by
- 398
- References
- 36
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.